TrialJournal of viral hepatitis2013

Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.

J Toyota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.